Search Results for keywords:"National Institute of Allergy and Infectious Diseases"

The National Institute of Allergy and Infectious Diseases is holding a closed meeting to review grant applications for the NIAID New Innovators Awards. The meeting will take place virtually on March 2-3, 2021, from 10:00 a.m. to 6:00 p.m. The discussions will include sensitive information, such as trade secrets and personal data, which is why the meeting is not open to the public. Jennifer H. Meyers, a Scientific Review Officer, can be contacted for more information.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 5, 2025. This meeting will focus on reviewing and evaluating contract proposals related to assessing the quality and reproducibility of data concerning therapeutics and vaccines. The session will be held from 10:00 a.m. to 3:00 p.m. and conducted through a video-assisted format. It is being closed to protect confidential information and personal privacy.

The National Institute of Allergy and Infectious Diseases (NIAID) has announced a closed meeting that will take place on April 17, 2025, from 9:00 a.m. to 11:00 a.m. This meeting is being held to review and evaluate grant applications and will not be open to the public. The discussions during the meeting might involve confidential information, including trade secrets and personal details, which is why it is closed to protect privacy. The meeting will occur at the NIAID in Rockville, MD, with video assistance, and it will be overseen by Dr. Maryam Rohani, a Scientific Review Officer at NIAID.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting on February 12, 2021, to review and evaluate grant applications. The meeting is not open to the public because it may reveal confidential trade secrets, commercial property, or personal information. The discussion will include applications for trial planning and clinical trial implementation grants. The notice was issued less than 15 days before the meeting because of time constraints related to the review and funding process.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting from April 14-16, 2025, to review and evaluate contract proposals related to the development of diagnostics for Mycoplasma genitalium infection. This meeting falls under specific federal regulations, which means it will not be open to the public to protect confidential and personal information. The discussions might involve trade secrets or sensitive commercial information. For more details, Dylan P. Flather, Ph.D., is the contact person available via email or phone.

The National Institute of Allergy and Infectious Diseases is announcing two closed meetings to review grant applications. These meetings are organized under sections 552b(c)(4) and 552b(c)(6) to protect confidential and personal information. The first meeting, focusing on a research education program, is scheduled for April 22, 2025, from 1:00 p.m. to 5:00 p.m. and will be conducted as a video-assisted meeting. The second meeting, related to AIDS Research Centers, will take place on April 28, 2025, from 10:00 a.m. to 4:00 p.m. and will be a virtual meeting. All discussions will take place at the NIH facility in Rockville, Maryland.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting of the Allergy, Immunology, and Transplantation Research Committee (AITC) on February 25-26, 2021. This meeting is closed to the public as it will involve discussions of confidential information concerning grant applications, which may include trade secrets and personal details of the applicants. The agenda of the meeting is to review and evaluate these grant applications. The virtual meeting will be held at the National Institutes of Health in Rockville, Maryland.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 8-9, 2021, to discuss grant applications concerning COVID-19 and SARS-CoV-2 research. The meeting will be virtual and closed to the public to protect confidential trade secrets and personal privacy. Participants will include grant reviewers evaluating the applications, and it is organized by Dr. Maryam Feili-Hariri. The discussion will cover programs related to allergy, immunology, and infectious diseases.

The National Institute of Allergy and Infectious Diseases announced a closed meeting on April 18, 2025, and another on April 28, 2025, to review and evaluate grant applications. Both meetings will be held via video and are closed to the public due to potential exposure of confidential information. Specific committees involved are the Allergy, Immunology, and Transplantation Research Committee and the Competitive Revision Supplements to Existing T32 Programs committee. Contact details for further information are offered through Vanitha S. Raman, Ph.D., at the National Institutes of Health.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 3-4, 2024, to review contract proposals related to vaccine adjuvant development. This meeting is closed to the public to protect sensitive information like trade secrets and personal privacy. The meeting will take place via video at the NIH facility in Rockville, MD. For further details, Michael M. Opata, Ph.D., is the contact person.